BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes
New data presented at ASCO underscores importance of genomic profiling for African-American women with breast cancer whose unique tumor biology can sometimes lead to poorer prognoses IRVINE, Calif., U.S. and AMSTERDAM, the Netherlands, June 01, 2019 / B3C …